05:26 PM EDT, 08/19/2024 (MT Newswires) -- Cidara Therapeutics ( CDTX ) said late Monday it appointed Jim Beitel as chief business officer, succeeding Preetam Shah, who will continue as chief financial officer.

Beitel most recently served as senior vice president of corporate development at Fate Therapeutics (FATE).

Price: 12.89, Change: -0.07, Percent Change: -0.54